ATRESMED.C.D.M.D.C.EO-,75ATRESMED.C.D.M.D.C.EO-,75ATRESMED.C.D.M.D.C.EO-,75

ATRESMED.C.D.M.D.C.EO-,75

No trades
See on Supercharts

YT2A fundamentals

ATRESMED.C.D.M.D.C.EO-,75 financial statements, including revenue, expenses, profit, and loss

The total revenue of YT2A for the last semiannual is 458.56 M EUR, and it's 7.25% higher compared to the previous semiannual. The net income of H2 23 is 111.36 M EUR.

Q1 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
Q1 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth